BN Business News
Unternehmen hinzufügen →
Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.

Regulierung & Recht · 21.10.20051 Min. Lesezeit

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patents and Patent Applications Concerning Bacterial Superantigen Vaccines

Lokale automatische Übersetzung · Originalsprache der Quelle

Zusammenfassung

In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent No. 6,399,332 entitled "Bacterial Superantigen Vaccines," issued June 4, 2002; U.S. Patent No. 6,713,284 entitled "Bacterial Superantigen Vaccines," issued March 30, 2004; U.S. Patent Application No. 10/757,687 entitled "Bacterial Superantigen Vaccines," filed January 29, 2004, which is a divisional of U.S. Patent No. 6,713,284; and U.S. Patent Application No. 10/002,784 entitled "Bacterial Superantigen Vaccines," filed November 26, 2001, which is a continuation in part of U.S. Patent No. 6,713,284. Foreign rights are also available (PCT/US98/16766 and PCT/ US01/46540). The United States Government, as represented by the Secretary of the Army, has rights in this invention.

Originalsprache der Quelle: Federal Register — All DocumentsOriginalquelle öffnen →

Weitere Themen

Business-Analysen →